Anemia in older persons

American Family Physician

Volumn 82, Issue 5, 2010, Pages 480-487

  Bross, Michael H ^a   Soch, Kathleen ^b   Smith Knuppel, Teresa ^c  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANEMIC AGENT; CYANOCOBALAMIN; FERRIC HYDROXIDE SUCROSE; FERRITIN; FERROUS GLUCONATE; FERROUS SULFATE; FOLIC ACID; HEMOGLOBIN; IRON COMPLEX; IRON DEXTRAN; LACTATE DEHYDROGENASE; RECOMBINANT ERYTHROPOIETIN; HOMOCYSTEINE; IRON DERIVATIVE; METHYLMALONIC ACID;

AGING; ANEMIA; ARTICLE; BLOOD CELL COUNT; BLOOD SMEAR; BLOOD TRANSFUSION; CHRONIC INFLAMMATION; CHRONIC KIDNEY DISEASE; COMMUNITY LIVING; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; CREATININE CLEARANCE; DRUG MEGADOSE; FERRITIN BLOOD LEVEL; FOLIC ACID BLOOD LEVEL; FOLIC ACID DEFICIENCY; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HEMATOCRIT; HEMATURIA; HEMOLYSIS; HUMAN; HYPERSPLENISM; INCIDENCE; IRON DEFICIENCY ANEMIA; IRON THERAPY; LABORATORY TEST; MACROCYTIC ANEMIA; MEAN CORPUSCULAR VOLUME; MICROCYTIC ANEMIA; MORBIDITY; MORTALITY; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; NORMOCHROMIC NORMOCYTIC ANEMIA; NURSING HOME; NUTRITIONAL DEFICIENCY; PREVALENCE; QUALITY OF LIFE; RETICULOCYTE COUNT; RETICULOCYTOSIS; RISK FACTOR; AGED; ALGORITHM; ANAMNESIS; BLOOD; FEMALE; INFLAMMATION; KIDNEY FAILURE; MALE; PHYSICAL EXAMINATION;

AGED; ALGORITHMS; ANEMIA; DEFICIENCY DISEASES; ERYTHROCYTE INDICES; FEMALE; FERRITINS; FOLIC ACID; HEMATINICS; HOMOCYSTEINE; HUMANS; INFLAMMATION; IRON COMPOUNDS; MALE; MEDICAL HISTORY TAKING; METHYLMALONIC ACID; PHYSICAL EXAMINATION; RENAL INSUFFICIENCY; RETICULOCYTE COUNT; VITAMIN B 12;

EID: 77957283688     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Anía BJ, Suman VJ, Fairbanks VF, Rademacher DM, Melton LJ III. Incidence of anemia in older people: an epidemiologic study in a well defined population. J Am Geriatr Soc. 1997;45(7):825-831.
2. Artz AS, Fergusson D, Drinka PJ, et al. Prevalence of anemia in skilled-nursing home residents. Arch Gerontol Geriatr. 2004;39(3):201-206.
3. Chaves PH, Ashar B, Guralnik JM, Fried LP. Looking at the relationship between hemoglobin concentration and prevalent mobility difficulty in older women. Should the criteria currently used to define anemia in older people be reevaluated? J Am Geriatr Soc. 2002;50(7):1527-1564.
4. Penninx BW, Pahor M, Cesari M, et al. Anemia is associated with disability and decreased physical performance and muscle strength in the elderly. J Am Geriatr Soc. 2004;52(5):719-724.
5. Thein M, Ershler WB, Artz AS, et al. Diminished quality of life and physical function in community-dwelling elderly with anemia. Medicine (Baltimore). 2009;88(2):107-114.
6. Agnihotri P, Telfer M, Butt Z, et al. Chronic anemia and fatigue in elderly patients: results of a randomized, double-blind, placebo-controlled, crossover exploratory study with epoetin alfa. J Am Geriatr Soc. 2007;55(10):1557-1565.
7. Beard CM, Kokmen E, O'Brien PC, Anía BJ, Melton LJ III. Risk of Alzheimer's disease among elderly patients with anemia: population-based investigations in Olmsted County, Minnesota. Ann Epidemiol. 1997;7(3):219-224.
8. Chaves PH, Carlson MC, Ferrucci L, Guralnik JM, Semba R, Fried LP. Association between mild anemia and executive function impairment in community-dwelling older women: The Women's Health and Aging Study II. J Am Geriatr Soc. 2006;54(9):1429-1435.
9. Joosten E, Lemiengre J, Nelis T, Verbeke G, Milisen K. Is anaemia a risk factor for delirium in an acute geriatric population? Gerontology. 2006;52(6):382-385.
10. Dharmarajan TS, Norkus EP. Mild anemia and the risk of falls in older adults from nursing homes and the community. J Am Med Dir Assoc. 2004;5(6):395-400.
11. Chaves PH, Xue QL, Guralnik JM, Ferrucci L, Volpato S, Fried LP. What constitutes normal hemoglobin concentration in community-dwelling disabled older women? J Am Geriatr Soc. 2004;52(11):1811-1816.
12. Zakai NA, Katz R, Hirsch C, et al. A prospective study of anemia status, hemoglobin concentration, and mortality in an elderly cohort: the Cardiovascular Health Study. Arch Intern Med. 2005;165(19):2214-2220.
13. Kikuchi M, Inagaki T, Shinagawa N. Five-year survival of older people with anemia: variation with hemoglobin concentration. J Am Geriatr Soc. 2001;49(9):1126-1128.
14. Meneveau N, Schiele F, Seronde MF, et al.; Reseau de Cardiologie de Franche Comte. Anemia for risk assessment of patients with acute coronary syndromes. Am J Cardiol. 2009;103(4):442-447.
15. Groenveld HF, Januzzi JL, Damman K, et al. Anemia and mortality in heart failure patients: a systematic review and meta-analysis. J Am Coll Cardiol. 2008;52(10):818-827.
16. McClellan WM, Flanders WD, Langston RD, Jurkovitz C, Presley R. Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-based study. J Am Soc Nephrol. 2002;13(7):1928-1936.
17. Beattie WS, Karkouti K, Wijeysundera DN, Tait G. Risk associated with preoperative anemia in noncardiac surgery: a single-center cohort study. Anesthesiology. 2009;110(3):574-581.
18. Penninx BW, Guralnik JM, Onder G, Ferrucci L, Wallace RB, Pahor M. Anemia and decline in physical performance among older persons. Am J Med. 2003;115(2):104-110.
19. National Center for Health Statistics. Third National Health and Nutrition Examination Survey (NHANES III), 1988-94. Hyattsville, Md.: National Center for Health Statistics; October 1996.
20. Guralnik JM, Eisenstaedt RS, Ferrucci L, Klein HG, Woodman RC. Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood. 2004;104(8):2263-2268.
21. Sheth TN, Choudhry NK, Bowes M, Detsky AS. The relation of conjunctival pallor to the presence of anemia. J Gen Intern Med. 1997;12(2):102-106.
22. Allen LH. Causes of vitamin B12 and folate deficiency. Food Nutr Bull. 2008;29(2 suppl):S20-S37.
23. Guyatt GH, Oxman AD, Ali M, Willan A, McIlroy W, Patterson C. Laboratory diagnosis of iron-deficiency anemia: an overview [published correction appears in J Gen Intern Med. 1992;7(4):423]. J Gen Intern Med. 1992;7(2):145-153.
24. Guyatt GH, Patterson C, Ali M, et al. Diagnosis of iron-deficiency anemia in the elderly. Am J Med. 1990;88(3):205-209.
25. Ble A, Fink JC, Woodman RC, et al. Renal function, erythropoietin, and anemia of older persons: the InCHIANTI study. Arch Intern Med. 2005;165(19):2222-2227.
26. Steensma DP, Tefferi A. Anemia in the elderly: how should we define it, when does it matter, and what can be done? Mayo Clin Proc. 2007;82(8):958-966.
27. Koulaouzidis A, Said E, Cottier R, Saeed AA. Soluble transferrin receptors and iron deficiency, a step beyond ferritin. A systematic review. J Gastrointestin Liver Dis. 2009;18(3):345-352.
28. Punnonen K, Irjala K, Rajamäki A. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood. 1997;89(3):1052-1057.
29. Rimon E, Levy S, Sapir A, et al. Diagnosis of iron deficiency anemia in the elderly by transferrin receptor-ferritin index. Arch Intern Med. 2002;162(4):445-449.
30. Koulaouzidis A, Cottier R, Bhat S, Said E, Linaker BD, Saeed AA. A ferritin level >50 microg/L is frequently consistent with iron deficiency. Eur J Intern Med. 2009;20(2):168-170.
31. Marchand A, Galen RS, Van Lente F. The predictive value of serum haptoglobin in hemolytic disease. JAMA. 1980;243(19):1909-1911.
32. Savage DG, Ogundipe A, Allen RH, Stabler SP, Lindenbaum J. Etiology and diagnostic evaluation of macrocytosis. Am J Med Sci. 2000;319(6):343-352.
33. Savage DG, Lindenbaum J, Stabler SP, Allen RH. Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies. Am J Med. 1994;96(3):239-246.
34. Mahmoud MY, Lugon M, Anderson CC. Unexplained macrocytosis in elderly patients. Age Ageing. 1996;25(4):310-312.
35. Ioannou GN, Rockey DC, Bryson CL, Weiss NS. Iron deficiency and gastrointestinal malignancy: a population-based cohort study. Am J Med. 2002;113(4):276-280.
36. Majid S, Salih M, Wasaya R, Jafri W. Predictors of gastrointestinal lesions on endoscopy in iron deficiency anemia without gastrointestinal symptoms. BMC Gastroenterol. 2008;8:52.
37. Arora G, Mannalithara A, Singh G, Gerson LB, Triadafilopoulos G. Risk of perforation from a colonoscopy in adults: a large population-based study. Gastrointest Endosc. 2009;69(3 pt 2):654-664.
38. Dierickx D, De Rycke A, Vanderschueren S, Delannoy A. New treatment options for immune-mediated hematological disorders. Eur J Intern Med. 2008;19(8):579-586.
39. Killip S, Bennett JM, Chambers MD. Iron deficiency anemia [published correction appears in Am Fam Physician. 2008;78(8):914]. Am Fam Physician. 2007;75(5):671-678.
40. Rimon E, Kagansky N, Kagansky M, et al. Are we giving too much iron? Low-dose iron therapy is effective in octogenarians. Am J Med. 2005;118(10):1142-1147.
41. Kuzminski AM, Del Giacco EJ, Allen RH, Stabler SP, Lindenbaum J. Effective treatment of cobalamin deficiency with oral cobalamin. Blood. 1998;92(4):1191-1198.
42. Bolaman Z, Kadikoylu G, Yukselen V, Yavasoglu I, Barutca S, Senturk T. Oral versus intramuscular cobalamin treatment in megaloblastic anemia: a single-center, prospective, randomized, open-label study. Clin Ther. 2003;25(12):3124-3134.
43. Andrès E, Dali-Youcef N, Vogel T, Serraj K, Zimmer J. Oral cobalamin (vitamin B(12) treatment. An update. Int J Lab Hematol. 2009;31(1):1-8.
44. KDOQI. KDOQI clinical practice guideline and clinical practice recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target. Am J Kidney Dis. 2007;50(3):471-530.
45. Rizzo JD, Somerfield MR, Hagerty KL, et al. Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update [published correction appears in Blood. 2008;111(7):3909]. Blood. 2008;111(1):25-41.
46. U.S. Food and Drug Administration. Information on erythropoiesis-stimulating agents (ESA) epoetin alfa (marketed as Procrit, Epogen) darbepoetin alfa (marketed as Aranesp). Safety announcement. http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm109375.htm. Accessed July 23, 2009.
47. Centers for Medicare and Medicaid Services. Erythropoietin stimulating agents policies. https://www.cms.gov/CoverageGenInfo/05_esapolicies.asp. Accessed June 17, 2010.
48. Singh AK, Szczech L, Tang KL, et al.; CHOIR Investigators. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med. 2006;355(20):2085-2098.
49. Pfeffer MA, Burdmann EA, Chen CY, et al.; TREAT Investigators. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med. 2009;361(21):2019-2032.
50. Unger EF, Thompson AM, Blank MJ, Temple R. Erythropoiesis-stimulating agents-time for a reevaluation. N Engl J Med. 2010;362(3):189-192.
51. Wright JR, Ung YC, Julian JA, et al. Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia. J Clin Oncol. 2007;25(9):1027-1032.
52. Scott BL, Ramakrishnan A, Storer B, et al. Prolonged responses in patients with MDS and CMML treated with azacitidine and etanercept. Br J Haematol. 2010;148(6):944-947.
53. Hulin C, Facon T, Rodon P, et al. Efficacy of melphalan and prednisone plus thalidomide in patients older than 75 years with newly diagnosed multiple myeloma: IFM 01/01 trial. J Clin Oncol. 2009;27(22):3664-3670.